Jahanvi Miller

As a Director of Quality for Amgen, Jahanvi oversees all of the Americas (North, Central & South; along with Canada), she helps to develop and shape global policy/regulations which are consistent with Amgen’s positions and priorities and share GxP intelligence throughout the organization. She also engages with internal stakeholders to meet and implement global regulatory expectations throughout the product-life cycle (incl. early-warning signals). She is the current chair of the PhRMA Quality GQM workstream and supports other QMM industry efforts, and is the co-chair of the ISPE Quality and Regulatory Advisory Board. Jahanvi comes to GQC (Global Quality Compliance) with over 20 years of industry experience from PDA (Parenteral Drug Association) where she was responsible for all regulatory activities and initiatives globally of the Science Advisory Board. She worked collaboratively with PDA members and governing bodies to facilitate the production of PDA Responses to Draft Regulatory Guidance Documents, Technical Reports, Points to Consider Guidance’s, Training Courses and Strategic Plans. Prior to joining PDA in 2012, Jahanvi worked as a clinical manager for Otsuka, an account director at OneWorld, and a research scientist at Johnson & Johnson. Jahanvi holds a Bachelor of Science Degree in Biomedical Sciences and a Master’s Degree in Business Management.